Apr 19, 2018 11:00 am UTC| Business
LOS ANGELES, April 19, 2018 -- Capricor Therapeutics (NASDAQ:CAPR) today announced that researchers found that repeat dosing of the company’s proprietary cellular therapy yields an increase in exercise performance in a...
Apr 19, 2018 11:00 am UTC| Business
BOULDER, Colo., April 19, 2018 -- miRagen Therapeutics, Inc. (NASDAQ:MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, announced today that it will be...
NeuroMetrix Reports Q1 2018 Financial Results
Apr 19, 2018 11:00 am UTC| Business
WALTHAM, Mass., April 19, 2018 -- NeuroMetrix, Inc. (Nasdaq:NURO), today reported financial and business highlights for the quarter ended March 31, 2018. The Company develops and markets novel therapies, based on...
Sandy Spring Bancorp Reports Net Income of $21.7 Million for the First Quarter of 2018
Apr 19, 2018 11:00 am UTC| Business
OLNEY, Md., April 19, 2018 -- Sandy Spring Bancorp, Inc., (Nasdaq:SASR), the parent company of Sandy Spring Bank, today reported net income for the first quarter of 2018 of $21.7 million ($0.61 per diluted share)...
WANdisco Fusion 2.11 now certified to run on Cloudera 5
Apr 19, 2018 11:00 am UTC| Business
SAN RAMON, Calif., April 19, 2018 -- WANdisco (LSE:WAND), the Live Data company, is pleased to announce its Live Data platform, WANdisco Fusion 2.11, is now certified to run on Cloudera 5 through the Cloudera Partner...
Manhattan Bridge Capital, Inc. Declares Quarterly Dividend
Apr 19, 2018 11:00 am UTC| Business
GREAT NECK, N.Y., April 19, 2018 -- Manhattan Bridge Capital, Inc. (NASDAQ:LOAN) announced today that, in accordance with the board approved dividend declared on April 18, 2018, a cash dividend of $0.12 per share will...
Apr 19, 2018 11:00 am UTC| Business
WATERTOWN, Mass., April 19, 2018 -- EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) (ASX:PVA), a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic products, will report...